SCHEMBL17899111

SCHEMBL17899111

CCCn1c(=O)c(C(=O)NCCN2CCNCC2)c(O)c2ccccc21

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.68
LMNA P02545 4/20 0.68
MEN1 O00255 6/20 0.68
KMT2A Q03164 6/20 0.68
POLB P06746 2/20 0.61
USP2 O75604 2/20 0.61
MAPT P10636 2/20 0.61
TSHR P16473 2/20 0.61
SMN1; SMN2 Q16637 2/20 0.61
HTT P42858 4/20 0.61
ALDH1A1 P00352 2/20 0.61
HPGD P15428 1/20 0.61
TP53 P04637 1/20 0.59
NPSR1 Q6W5P4 1/20 0.59
RXFP1 Q9HBX9 1/20 0.59
GAA P10253 1/20 0.59
ALOX15 P16050 1/20 0.57
MAPK1 P28482 1/20 0.57
HSD17B10 Q99714 1/20 0.57
L3MBTL1 Q9Y468 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16426639 0.93 KDM4E (0.79) KDM4ELMNAMEN1KMT2ATSHR
SCHEMBL38659448 0.81 MEN1 (0.73) KDM4ELMNAMEN1KMT2APOLB
SCHEMBL38660692 0.79 MEN1 (0.76) KDM4ELMNAMEN1KMT2APOLB
SCHEMBL38659938 0.76 MEN1 (0.68) KDM4ELMNAMEN1KMT2APOLB
SCHEMBL10674767 0.76 MEN1 (1.00) KDM4ELMNAMEN1KMT2AUSP2
SCHEMBL13726550 0.76 SMN1; SMN2 (0.70) KDM4ELMNAMEN1KMT2APOLB
SCHEMBL17899115 0.75 KDM4E (0.80) KDM4ELMNAMEN1KMT2APOLB
SCHEMBL38659614 0.75 TDP1 (0.75) KDM4ELMNAMEN1KMT2APOLB
SCHEMBL6950902 0.75 HSD17B10 (0.51) KDM4EMEN1KMT2ASMN1; SMN2ALDH1A1
SCHEMBL12869734 0.75 MEN1 (0.84) KDM4ELMNAMEN1KMT2APOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10266527-B2 T-box riboswitch-binding anti-bacterial compounds THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF ALBANY (US) 2019-04-23 US disclosed
US-20160194317-A1 T-BOX RIBOSWITCH-BINDING ANTI-BACTERIAL COMPOUNDS THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK (US) 2016-07-07 US disclosed
US-20160194317-A1 T-BOX RIBOSWITCH-BINDING ANTI-BACTERIAL COMPOUNDS THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK (US) 2016-07-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10266527-B2 T-box riboswitch-binding anti-bacterial compounds TARBP1, AARS1, NSUN3 KDM4E 2123/4885LMNA 4231/4885MEN1 4763/4885
US-20160194317-A1 T-BOX RIBOSWITCH-BINDING ANTI-BACTERIAL COMPOUNDS TARBP1, AARS1, NSUN3 KDM4E 2123/4885LMNA 4231/4885MEN1 4763/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.